Work

Phase I clinical trial using selective cyclooxygenase-2 (COX-2) inhibitor celecoxib with concurrent thoracic irradiation in patients with poor prognosis non-small cell lung cancer (NSCLC)

Year: 2004

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2004.06.063

Authors: Z. Liao, R. Komaki, L. Milas, Y. Chen, J.Y. Chang, M. Jeter, T. Guerrero, S.W. Craig, G. Blumenschien, C.M. Smith, J.D. Cox

Institutions: University of Houston, Tongji Hospital, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2061394988

FWCI: 0.643

Cites:

Cited by: 5

Related to: 10